XML 38 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

Restructuring | 12 Months Ended
--- | ---
May 31, 2026
Restructuring and Related Activities [Abstract] |
Restructuring | 7. Restructuring The Company regularly evaluates its business and objectives to ensure that it is properly configured and sized based on changing market conditions. Accordingly, the Company has implemented certain restructuring initiatives, including consolidation of certain facilities throughout the world and rationalization of its operations. In the second quarter of fiscal year 2026, management initiated a restructuring plan to right-size our cost base through a reduction of approximately 10% in global headcount, including both existing and planned positions, as well as additional non-labor cost reductions. As of May 31, 2026, the Company has incurred cumulative restructuring charges of $6.7 million for the fiscal year 2026 restructuring plan, which is completed. In the second quarter of fiscal year 2025, management initiated a restructuring plan primarily designed to focus the end market exposure and streamline operations of the Company's global genomics business, which was completed as of May 31, 2025. The Company’s restructuring charges consist of severance payments, costs for outplacement services, and post-employment benefits (collectively, “employee separation costs”), other related exit costs and asset impairment charges related to restructuring activities. These amounts are partially recorded within cost of service revenues and partially recorded within general and administrative expense on the consolidated statements of operations. Restructuring charges by segment were as follows:
|  | Year ended May 31, |
|  | 2026 |  |  | 2025 |
Food Safety |  | $ | 3.4 |  |  | $ | 2.2 |
Animal Safety |  |  | 0.6 |  |  |  | 7.4 |
Corporate |  |  | 3.0 |  |  |  | 1.5 |
Total |  | $ | 7.0 |  |  | $ | 11.1 |
Restructuring activity for the twelve months ended May 31, 2026 was as follows:
|  | Employee Separation Costs |  |  | Other Exit Costs |  |  | Total |
Balance as of May 31, 2025 |  | $ | 0.8 |  |  | $ | — |  |  | $ | 0.8 |
Expense |  |  | 7.1 |  |  |  | (0.1 | ) |  |  | 7.0 |
Cash Payments |  |  | (7.3 | ) |  |  | — |  |  |  | (7.3 | )
Asset impairments and other (1) |  |  | — |  |  |  | 0.1 |  |  |  | 0.1 |
Balance as of May 31, 2026 |  | $ | 0.6 |  |  | $ | — |  |  | $ | 0.6 |
(1) Asset impairments relate to charges incurred by the Company's Animal Safety operating segment and global genomics business.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/420/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration